IMPACT-MH

AWARDEES

IMPACT-MH Awardees

1U24MH136069-01

Data Coordination Center (DCC)

Coordinating Individually Measured Phenotypes to Advance Mental Health Research

Yale University

1U01MH136535-01

PREDiCTOR

Phenotypes REimagined to Define Clinical Treatment and Outcome

Icahn School of Medicine at Mount Sinai

The project aims to leverage rich behavioral datasets from routine clinical visits and smartphones, including verbal and nonverbal communication during clinical interviews, EHRs, smartphone passive monitoring, and audio diary entries, to develop baseline and longitudinal clinical signatures to predict clinically relevant outcomes, i.e., treatment disengagement, ER visits and hospitalizations, among young help-seeking individuals.

1U01MH136497-01

IMPACT-Y

Clinical and behavioral fingerprints of psychopathology

Yale University

This project aims to identify predictive markers of symptom change using assessments readily deployable in real-world settings, including EHRs, traditional clinical measures, computational behavioral tasks, short gamified measures of mood and reward, spoken narrative data for natural language processing analyses, and transdiagnostic outcome measures. Longitudinal data will be collected over two years from 2,400 individuals, enriched for psychopathology across a broad spectrum of traditional diagnoses, and analyses will seek to identify a minimum set of measures with maximum added clinical value, examine longitudinal clinical trajectories, and identify subgroups with different clinical outcomes over 2-years.

IMPACT Point People

Connecting the DCC to our research partners

IMPACT 组织关系图
DCC
Na Hong
Fang Li
Sarah
Lichenstein
Christian
Horgan
Isaac Clark
Nan Huo
Kalpana
Raja
OHSU

OHSU

Oregon Health & Science University project

ACE-D

ACE-D

Deriving a cognitive-control signature for depression and testing it to guide treatment choice.

HALO

HALO

Separating dangerous from benign hallucinations to target urgent care only when needed.

TRACC

TRACC

Validating dynamic cognitive phenotypes to better time interventions for serious mental illness.

Duke-PMA

Duke-PMA

Validating low-burden models predicting adolescent psychiatric risk up to a year ahead.

SPARC-XP

SPARC-XP

Building scalable phenotyping to estimate neurodevelopmental risk from prenatal infection exposure.

JASPer

JASPer

Modeling youth trajectories to trigger scalable stepped-care before school/work is derailed.

COMPASS

COMPASS

Matching patients to digital vs clinic care across episodes for timely, personalized treatment.

ARTEMIS

ARTEMIS

Identifying imminent shifts in suicide risk—who, which signals, and when—for actionable care.

PREDICTOR

PREDICTOR

Combining interviews, smartphone passives, and EHR text to predict disengagement, ER use, and hospitalization.

REACH

REACH

Creating remote behavioral screening to catch externalizing problems early and direct support.

PPSN

PPSN

Using sleep-based markers to flag pediatric risk earlier in primary care.

IMPACT-Yale

IMPACT-Yale

Building multimodal "clinical fingerprints" from EHR, tasks, and speech to forecast symptoms and outcomes.